Sign In

David Johnson

CEO at GigaGen

Dr. David Johnson is a renowned inventor, entrepreneur, and expert in single-cell genomics, notable for his success in introducing innovative medical technologies to the market.

As the Founder and CEO of GigaGen, he has secured over $65 million in funding to develop cutting-edge technologies for immune repertoire genomics, leading to the creation of groundbreaking antibody therapies with applications in oncology and immunology.

Prior to his role at GigaGen, Dr. Johnson was a pivotal figure and the Chief Operating Officer (COO) at Natera, a publicly-traded company (NASDAQ: NTRA), where he oversaw clinical operations, laboratory research, clinical studies, and the development of clinical products.

His impressive academic background includes a Bachelor of Science (BS) in Biology from Duke University, a Doctorate in Genetics from Stanford University, and a Master of Business Administration (MBA) from the Haas School of Business at the University of California, Berkeley.

Dr. Johnson's expertise extends beyond traditional academic pursuits, as evidenced by his participation in various educational programs around the globe, including visits to the Tokyo Institute of Technology for Genetics studies and Universidad San Francisco de Quito for Biology studies.

Throughout his career, Dr. Johnson has shown a consistent commitment to advancing the field of genomics and biotechnology, evident in his leadership roles at prestigious institutions and cutting-edge companies.

With a wealth of experience in both academia and the corporate sector, Dr. Johnson continues to make significant contributions to the scientific and business communities, solidifying his reputation as a top-tier professional in the field.

David Johnson
Add to my network

Location

San Francisco, California